VIM and clear cell renal carcinoma: Immunohistochemistry for CD10, vimentin, and renal cell carcinoma antigen were entirely negative, arguing against a collision between an oncocytoma and a high-grade clear cell renal cell carcinoma and supporting a progression of the disease.